Patent Document ID: 20160030376
Application ID: 14879744
Patent Flag: 0

Claim One:
1. A method of treatment for Alzheimer's disease, comprising the steps of: a. selecting a patient having, or at risk of Alzheimer's disease; b. determining in the patient the presence of at least one of the specific genotypes selected from the group consisting of: i. heterozygosity for A/C of Apolipoprotein E (ApoE) rs405509 at relevant portion shown by SEQ ID NO:21, ii. heterozygosity for G/A of Butyrylcholine esterase (BUCHE) rs1803274 at relevant portion shown by SEQ ID NO:18, iii. homozygosity for adenine of Insulin-like Growth Factor Receptor Precursor (IGF1R) rs2229765 at relevant portion shown by SEQ ID NO:6, iv. homozygosity for thymine of Interleukin-1 beta (IL1B) rs1143627 at relevant portion shown by SEQ ID NO:9, v. homozygosity for cytosine of IL1B rs16944 at relevant portion shown by SEQ ID NO:10, vi. homozygosity for cytosine of Low-density Lipoprotein Receptor (LDLR) rs2738447 at relevant portion shown by SEQ ID NO:24, vii. homozygosity for guanine of LDLR rs7259278 at relevant portion shown by SEQ ID NO:25, and viii. homozygosity for cytosine of LDLR rs1799898 at relevant portion shown by SEQ ID NO:15; and c. administering to the patient having at least one of the specific genotypes in (b) a composition comprising an effective amount of a composition comprising medium chain triglycerides (MCT) of the formula: wherein the R1, R2, and R3 esterified to the glycerol backbone are each independently fatty acids having 5-12 carbon chains.